Federated Hermes, Inc. Merus N.V. Transaction History

Federated Hermes, Inc.

$41.2 Billion
Q2 2024

A detailed history of Federated Hermes, Inc. transactions in Merus N.V. stock. As of the latest transaction made, Federated Hermes, Inc. holds 2,398,800 shares of MRUS stock, worth $121 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

2,398,800

Previous 2,248,800 6.67%

Holding current value

$121 Million

Previous $101 Million 40.17%

% of portfolio

0.34%

Previous 0.24%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$39.81 - $60.2 $5.97 Million - $9.03 Million	150,000 Added 6.67%	2,398,800 $142 Million
Q1 2024 May 14, 2024	SELL	$28.03 - $51.82 $38.9 Million - $72 Million	-1,388,509 Reduced 38.17%	2,248,800 $101 Million
Q4 2023 Jan 31, 2024	BUY	$20.06 - $28.66 $15.1 Million - $21.5 Million	751,609 Added 26.05%	3,637,309 $100 Million
Q3 2023 Nov 13, 2023	BUY	$20.13 - $27.29 $4.97 Million - $6.74 Million	247,000 Added 9.36%	2,885,700 $68 Million
Q1 2023 May 08, 2023	SELL	$14.25 - $20.5 $18.3 Million - $26.4 Million	-1,285,595 Reduced 32.76%	2,638,700 $48.6 Million
Q4 2022 Feb 13, 2023	BUY	$12.8 - $23.66 $4.18 Million - $7.73 Million	326,695 Added 9.08%	3,924,295 $60.7 Million
Q3 2022 Nov 14, 2022	BUY	$18.64 - $28.93 $89,472 - $138,864	4,800 Added 0.13%	3,597,600 $72.1 Million
Q2 2022 Aug 15, 2022	SELL	$13.98 - $29.25 $1.21 Million - $2.53 Million	-86,500 Reduced 2.35%	3,592,800 $81.3 Million
Q4 2021 Feb 14, 2022	BUY	$20.0 - $32.29 $14.9 Million - $24 Million	744,500 Added 25.37%	3,679,300 $117 Million
Q3 2021 Nov 15, 2021	SELL	$16.48 - $27.23 $737,199 - $1.22 Million	-44,733 Reduced 1.5%	2,934,800 $64.6 Million
Q2 2021 Aug 16, 2021	SELL	$20.0 - $25.48 $2.09 Million - $2.67 Million	-104,724 Reduced 3.4%	2,979,533 $62.8 Million
Q1 2021 May 13, 2021	BUY	$16.14 - $29.11 $2.38 Million - $4.29 Million	147,459 Added 5.02%	3,084,257 $64.4 Million
Q4 2020 Feb 12, 2021	BUY	$11.4 - $18.36 $4.7 Million - $7.56 Million	411,862 Added 16.31%	2,936,798 $51.5 Million
Q3 2020 Nov 12, 2020	BUY	$10.57 - $16.0 $906,271 - $1.37 Million	85,740 Added 3.52%	2,524,936 $30.3 Million
Q2 2020 Aug 13, 2020	BUY	$10.5 - $17.36 $6.59 Million - $10.9 Million	627,196 Added 34.61%	2,439,196 $39.2 Million
Q1 2020 May 13, 2020	BUY	$11.34 - $19.44 $8.33 Million - $14.3 Million	734,605 Added 68.18%	1,812,000 $21.9 Million
Q4 2019 Feb 14, 2020	BUY	$14.08 - $18.5 $12.1 Million - $15.9 Million	857,395 Added 389.73%	1,077,395 $15.2 Million
Q3 2019 Nov 14, 2019	BUY	$14.55 - $20.52 $2.28 Million - $3.21 Million	156,495 Added 246.43%	220,000 $3.92 Million
Q2 2019 Aug 14, 2019	BUY	$12.93 - $16.83 $821,119 - $1.07 Million	63,505 New	63,505 $930,000

Others Institutions Holding MRUS

# of Institutions

194

Shares Held

59.1M

Call Options Held

345K

Put Options Held

222K

View Full List

About Merus N.V.

Ticker MRUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,878,200
Market Cap $2.31B
Description
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...

More about MRUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Merus N.V. Transaction History